Ultromics

About

Ultromics clinicians and engineers working together to set new standards for world-class cardiovascular diagnostic tools.

Oxford,Oxfordshire,United Kingdom
1 - 10
http://www.ultromics.com/

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $10M
Industries: Artificial Intelligence,Computer Vision,Health Care,Health Diagnostics,Medical,Software
Founded date: Jan 1, 2017
Number Of Employee: 1 - 10
Operating Status: Active
Legal Name: Ultromics Limited

They are building world-class diagnostic aids to help cardiologists — powered by artificial intelligence.
To date, they have developed the world’s most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$10M £35.70M

Ultromics has raised a total of $10M £35.70M in funding over 2 rounds. Their latest funding was raised on Aug 16, 2021 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 16, 2021	Series B	£23.70M	4	BlueCross BlueShield Venture Partners	—	Detail
Jun 15, 2020	Series A	$10M	1	—	—	Detail
Nov 1, 2019	Funding Round	—	1	—	—	Detail
May 22, 2018	Series A	£10M	9	Oxford Science Enterprises	—	Detail
May 1, 2017	Seed	£2M	1	Oxford Science Enterprises	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

13

Ultromics is funded by 13 investors. BlueCross BlueShield Venture Partners and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
BlueCross BlueShield Venture Partners	Yes	Series B
GV	—	Series B
Optum Ventures	—	Series B
Oxford Science Enterprises	—	Series B
Nina Capital	—	Series A
Future Planet Capital	—	Funding Round
Andre Crawford-Brunt	—	Series A
Dieter Spälti	—	Series A
Fushia Investments	—	Series A
GT Healthcare Capital Partners	—	Series A